Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 107 entries
Sorted by: Best Match Show Resources per page
Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment.

Oncoimmunology

Tan KW, Evrard M, Tham M, Hong M, Huang C, Kato M, Prevost-Blondel A, Donnadieu E, Ng LG, Abastado JP.
PMID: 25949877
Oncoimmunology. 2015 Feb 25;4(2):e978709. doi: 10.4161/2162402X.2014.978709. eCollection 2015 Feb.

The infiltration of T lymphocytes within tumors is associated with better outcomes in cancer patients, yet current understanding of factors that influence T-lymphocyte infiltration into tumors remains incomplete. In our study, Temozolomide (TMZ), a chemotherapeutic drug used to treat...

Cite
Tan KW, Evrard M, Tham M, et al. Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment. Oncoimmunology. 2015;4(2):e978709doi: 10.4161/2162402X.2014.978709.
Tan, K. W., Evrard, M., Tham, M., Hong, M., Huang, C., Kato, M., Prevost-Blondel, A., Donnadieu, E., Ng, L. G., & Abastado, J. P. (2015). Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment. Oncoimmunology, 4(2), e978709. https://doi.org/10.4161/2162402X.2014.978709
Tan, Kar Wai, et al. "Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment." Oncoimmunology vol. 4,2 (2015): e978709. doi: https://doi.org/10.4161/2162402X.2014.978709
Tan KW, Evrard M, Tham M, Hong M, Huang C, Kato M, Prevost-Blondel A, Donnadieu E, Ng LG, Abastado JP. Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment. Oncoimmunology. 2015 Feb 25;4(2):e978709. doi: 10.4161/2162402X.2014.978709. eCollection 2015 Feb. PMID: 25949877; PMCID: PMC4404877.
Copy Download .nbib Format: NLM
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo.

European thyroid journal

Pilli T, Cantara S, Schomburg L, Cenci V, Cardinale S, Heid EC, Kühn EC, Cevenini G, Sestini F, Fioravanti C, D'Hauw G, Pacini F.
PMID: 26835425
Eur Thyroid J. 2015 Dec;4(4):226-33. doi: 10.1159/000439589. Epub 2015 Oct 08.

BACKGROUND: Several studies have suggested that selenium may influence the natural history of autoimmune thyroiditis (AIT). Recently, IFNγ-inducible chemokines (CXCL-9, -10 and -11) were shown to be elevated in AIT patients.OBJECTIVE: This prospective, randomized, controlled study was conducted to...

Cite
Pilli T, Cantara S, Schomburg L, et al. IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo. Eur Thyroid J. 2015;4(4):226-33doi: 10.1159/000439589.
Pilli, T., Cantara, S., Schomburg, L., Cenci, V., Cardinale, S., Heid, E. C., Kühn, E. C., Cevenini, G., Sestini, F., Fioravanti, C., D'Hauw, G., & Pacini, F. (2015). IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo. European thyroid journal, 4(4), 226-33. https://doi.org/10.1159/000439589
Pilli, Tania, et al. "IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo." European thyroid journal vol. 4,4 (2015): 226-33. doi: https://doi.org/10.1159/000439589
Pilli T, Cantara S, Schomburg L, Cenci V, Cardinale S, Heid EC, Kühn EC, Cevenini G, Sestini F, Fioravanti C, D'Hauw G, Pacini F. IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo. Eur Thyroid J. 2015 Dec;4(4):226-33. doi: 10.1159/000439589. Epub 2015 Oct 08. PMID: 26835425; PMCID: PMC4716423.
Copy Download .nbib Format: NLM
Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection.

International journal of organ transplantation medicine

Ciftci HS, Tefik T, Savran MK, Demir E, Caliskan Y, Ogret YD, Oktar T, Sanlı O, Kocak T, Ozluk Y, Oguz FS, Kilicaslan I, Aydın F, Turkmen A, Nane I.
PMID: 31285802
Int J Organ Transplant Med. 2019;10(2):53-63. Epub 2019 May 01.

BACKGROUND: Monitoring of chemokines, CXCL9 and CXCL10, in serum may present a non-invasive detection method for rejection.OBJECTIVE: To investigate the relationship between urinary levels of CXCL9 and CXCL10 and graft function following renal transplantation.METHODS: 75 living-related donor renal transplant...

Cite
Ciftci HS, Tefik T, Savran MK, et al. Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection. Int J Organ Transplant Med. 2019;10(2):53-63
Ciftci, H. S., Tefik, T., Savran, M. K., Demir, E., Caliskan, Y., Ogret, Y. D., Oktar, T., Sanlı, O., Kocak, T., Ozluk, Y., Oguz, F. S., Kilicaslan, I., Aydın, F., Turkmen, A., & Nane, I. (2019). Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection. International journal of organ transplantation medicine, 10(2), 53-63.
Ciftci, H S, et al. "Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection." International journal of organ transplantation medicine vol. 10,2 (2019): 53-63.
Ciftci HS, Tefik T, Savran MK, Demir E, Caliskan Y, Ogret YD, Oktar T, Sanlı O, Kocak T, Ozluk Y, Oguz FS, Kilicaslan I, Aydın F, Turkmen A, Nane I. Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection. Int J Organ Transplant Med. 2019;10(2):53-63. Epub 2019 May 01. PMID: 31285802; PMCID: PMC6604756.
Copy Download .nbib Format: NLM
Human Novel MicroRNA Seq-915_x4024 in Keratinocytes Contributes to Skin Regeneration by Suppressing Scar Formation.

Molecular therapy. Nucleic acids

Zhao F, Lang H, Wang Z, Zhang T, Zhang D, Wang R, Lin X, Liu X, Shi P, Pang X.
PMID: 30731322
Mol Ther Nucleic Acids. 2019 Mar 01;14:410-423. doi: 10.1016/j.omtn.2018.12.016. Epub 2019 Jan 10.

Early in gestation, wounds in fetal skin heal by regeneration, in which microRNAs play key roles. Seq-915_x4024 is a novel microRNA candidate confirmed by deep sequencing and mirTools 2.0. It is highly expressed in fetal keratinocytes during early gestation....

Cite
Zhao F, Lang H, Wang Z, et al. Human Novel MicroRNA Seq-915_x4024 in Keratinocytes Contributes to Skin Regeneration by Suppressing Scar Formation. Mol Ther Nucleic Acids. 2019;14:410-423doi: 10.1016/j.omtn.2018.12.016.
Zhao, F., Lang, H., Wang, Z., Zhang, T., Zhang, D., Wang, R., Lin, X., Liu, X., Shi, P., & Pang, X. (2019). Human Novel MicroRNA Seq-915_x4024 in Keratinocytes Contributes to Skin Regeneration by Suppressing Scar Formation. Molecular therapy. Nucleic acids, 14410-423. https://doi.org/10.1016/j.omtn.2018.12.016
Zhao, Feng, et al. "Human Novel MicroRNA Seq-915_x4024 in Keratinocytes Contributes to Skin Regeneration by Suppressing Scar Formation." Molecular therapy. Nucleic acids vol. 14 (2019): 410-423. doi: https://doi.org/10.1016/j.omtn.2018.12.016
Zhao F, Lang H, Wang Z, Zhang T, Zhang D, Wang R, Lin X, Liu X, Shi P, Pang X. Human Novel MicroRNA Seq-915_x4024 in Keratinocytes Contributes to Skin Regeneration by Suppressing Scar Formation. Mol Ther Nucleic Acids. 2019 Mar 01;14:410-423. doi: 10.1016/j.omtn.2018.12.016. Epub 2019 Jan 10. PMID: 30731322; PMCID: PMC6365370.
Copy Download .nbib Format: NLM
The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer.

Translational oncology

Lee SJ, Kim JE, Kim ST, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY.
PMID: 29448202
Transl Oncol. 2018 Apr;11(2):353-357. doi: 10.1016/j.tranon.2018.01.007. Epub 2018 Feb 20.

BACKGROUND: Biliary tract cancers (BTCs) are known to have a dismal prognosis. A number of chemokines play important roles in the progress of BTCs. However, the serum levels of chemokines in BTCs have not yet been explored.METHODS: The sera...

Cite
Lee SJ, Kim JE, Kim ST, et al. The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer. Transl Oncol. 2018;11(2):353-357doi: 10.1016/j.tranon.2018.01.007.
Lee, S. J., Kim, J. E., Kim, S. T., Lee, J., Park, S. H., Park, J. O., Kang, W. K., Park, Y. S., & Lim, H. Y. (2018). The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer. Translational oncology, 11(2), 353-357. https://doi.org/10.1016/j.tranon.2018.01.007
Lee, Su Jin, et al. "The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer." Translational oncology vol. 11,2 (2018): 353-357. doi: https://doi.org/10.1016/j.tranon.2018.01.007
Lee SJ, Kim JE, Kim ST, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY. The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer. Transl Oncol. 2018 Apr;11(2):353-357. doi: 10.1016/j.tranon.2018.01.007. Epub 2018 Feb 20. PMID: 29448202; PMCID: PMC5852407.
Copy Download .nbib Format: NLM
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.

Oncoimmunology

Eissler N, Mao Y, Brodin D, Reuterswärd P, Andersson Svahn H, Johnsen JI, Kiessling R, Kogner P.
PMID: 28123870
Oncoimmunology. 2016 Sep 09;5(12):e1232222. doi: 10.1080/2162402X.2016.1232222. eCollection 2016.

Removal of immuno-suppression has been reported to enhance antitumor immunity primed by checkpoint inhibitors. Although PD-1 blockade failed to control tumor growth in a transgenic murine neuroblastoma model, concurrent inhibition of colony stimulating factor 1 receptor (CSF-1R) by BLZ945...

Cite
Eissler N, Mao Y, Brodin D, et al. Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade. Oncoimmunology. 2016;5(12):e1232222doi: 10.1080/2162402X.2016.1232222.
Eissler, N., Mao, Y., Brodin, D., Reuterswärd, P., Andersson Svahn, H., Johnsen, J. I., Kiessling, R., & Kogner, P. (2016). Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade. Oncoimmunology, 5(12), e1232222. https://doi.org/10.1080/2162402X.2016.1232222
Eissler, Nina, et al. "Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade." Oncoimmunology vol. 5,12 (2016): e1232222. doi: https://doi.org/10.1080/2162402X.2016.1232222
Eissler N, Mao Y, Brodin D, Reuterswärd P, Andersson Svahn H, Johnsen JI, Kiessling R, Kogner P. Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade. Oncoimmunology. 2016 Sep 09;5(12):e1232222. doi: 10.1080/2162402X.2016.1232222. eCollection 2016. PMID: 28123870; PMCID: PMC5214950.
Copy Download .nbib Format: NLM
Role of CXC group chemokines in lung cancer development and progression.

Journal of thoracic disease

Spaks A.
PMID: 28446981
J Thorac Dis. 2017 Apr;9:S164-S171. doi: 10.21037/jtd.2017.03.61.

BACKGROUND: Clinical and translational research on lung cancer patients undergoing surgical treatment can provide valuable scientific data and unique opportunity to study tumor microenvironment. CXC chemokines, which are members of a big family of cytokines, are undoubtedly involved in...

Cite
Spaks A. Role of CXC group chemokines in lung cancer development and progression. J Thorac Dis. 2017;9:S164-S171doi: 10.21037/jtd.2017.03.61.
Spaks, A. (2017). Role of CXC group chemokines in lung cancer development and progression. Journal of thoracic disease, 9S164-S171. https://doi.org/10.21037/jtd.2017.03.61
Spaks, Artjoms. "Role of CXC group chemokines in lung cancer development and progression." Journal of thoracic disease vol. 9 (2017): S164-S171. doi: https://doi.org/10.21037/jtd.2017.03.61
Spaks A. Role of CXC group chemokines in lung cancer development and progression. J Thorac Dis. 2017 Apr;9:S164-S171. doi: 10.21037/jtd.2017.03.61. PMID: 28446981; PMCID: PMC5392545.
Copy Download .nbib Format: NLM
Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice.

Frontiers in systems neuroscience

Guo M, Chang P, Hauke E, Girard BM, Tooke K, Ojala J, Malley SM, Hsiang H, Vizzard MA.
PMID: 29681802
Front Syst Neurosci. 2018 Apr 06;12:9. doi: 10.3389/fnsys.2018.00009. eCollection 2018.

Changes in urinary bladder function and somatic sensation may be mediated, in part, by inflammatory changes in the urinary bladder including the expression of chemokines. Male and female C57BL/6 mice were treated with cyclophosphamide (CYP; 75 mg/kg, 200 mg/kg,...

Cite
Guo M, Chang P, Hauke E, et al. Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice. Front Syst Neurosci. 2018;12:9doi: 10.3389/fnsys.2018.00009.
Guo, M., Chang, P., Hauke, E., Girard, B. M., Tooke, K., Ojala, J., Malley, S. M., Hsiang, H., & Vizzard, M. A. (2018). Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice. Frontiers in systems neuroscience, 129. https://doi.org/10.3389/fnsys.2018.00009
Guo, Michael, et al. "Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice." Frontiers in systems neuroscience vol. 12 (2018): 9. doi: https://doi.org/10.3389/fnsys.2018.00009
Guo M, Chang P, Hauke E, Girard BM, Tooke K, Ojala J, Malley SM, Hsiang H, Vizzard MA. Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice. Front Syst Neurosci. 2018 Apr 06;12:9. doi: 10.3389/fnsys.2018.00009. eCollection 2018. PMID: 29681802; PMCID: PMC5897511.
Copy Download .nbib Format: NLM
Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats.

Journal of clinical medicine

Lin CF, Su CJ, Liu JH, Chen ST, Huang HL, Pan SL.
PMID: 31083544
J Clin Med. 2019 May 11;8(5). doi: 10.3390/jcm8050659.

The chemokines CXCL9 and CCL20 have been reported to be associated with ventricular dysfunction. This study was aimed to investigate the effects of CXCL9/CCL20 on cardiac fibrosis following myocardial infarction (MI). Blood samples of patients with MI were obtained...

Cite
Lin CF, Su CJ, Liu JH, et al. Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. J Clin Med. 2019;8(5)doi: 10.3390/jcm8050659.
Lin, C. F., Su, C. J., Liu, J. H., Chen, S. T., Huang, H. L., & Pan, S. L. (2019). Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. Journal of clinical medicine, 8(5), . https://doi.org/10.3390/jcm8050659
Lin, Chao-Feng, et al. "Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats." Journal of clinical medicine vol. 8,5 (2019). doi: https://doi.org/10.3390/jcm8050659
Lin CF, Su CJ, Liu JH, Chen ST, Huang HL, Pan SL. Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. J Clin Med. 2019 May 11;8(5). doi: 10.3390/jcm8050659. PMID: 31083544; PMCID: PMC6572441.
Copy Download .nbib Format: NLM
Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Huoman J, Haider S, Simpson A, Murray CS, Custovic A, Jenmalm MC.
PMID: 34101271
Pediatr Allergy Immunol. 2021 Nov;32(8):1824-1832. doi: 10.1111/pai.13574. Epub 2021 Jun 28.

BACKGROUND: Chemokines are important mediators in immune cell recruitment, contributing to allergy development. However, extensive studies of chemokines in the circulation in relation to the presence and development of allergic diseases remain scarce. Our aim was to investigate associations...

Cite
Huoman J, Haider S, Simpson A, et al. Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development. Pediatr Allergy Immunol. 2021;32(8):1824-1832doi: 10.1111/pai.13574.
Huoman, J., Haider, S., Simpson, A., Murray, C. S., Custovic, A., & Jenmalm, M. C. (2021). Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 32(8), 1824-1832. https://doi.org/10.1111/pai.13574
Huoman, Johanna, et al. "Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development." Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology vol. 32,8 (2021): 1824-1832. doi: https://doi.org/10.1111/pai.13574
Huoman J, Haider S, Simpson A, Murray CS, Custovic A, Jenmalm MC. Childhood CCL18, CXCL10 and CXCL11 levels differentially relate to and predict allergy development. Pediatr Allergy Immunol. 2021 Nov;32(8):1824-1832. doi: 10.1111/pai.13574. Epub 2021 Jun 28. PMID: 34101271.
Copy Download .nbib Format: NLM
Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Jouve T, Laheurte C, Noble J, Weinhard J, Daligault M, Renaudin A, Naciri Bennani H, Masson D, Gravelin E, Bugnazet M, Bardy B, Malvezzi P, Saas P, Rostaing L.
PMID: 34080291
Am J Transplant. 2022 Jan;22(1):71-84. doi: 10.1111/ajt.16709. Epub 2021 Jun 23.

Kidney transplant candidates (KTCs) who are HLA highly sensitized (calculated panel-reactive alloantibodies >95%) have poor access to deceased kidney transplantation. In this single-center prospective study, 13 highly sensitized desensitization-naïve KTCs received IV tocilizumab (8 mg/kg) every 4 weeks. We...

Cite
Jouve T, Laheurte C, Noble J, et al. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. Am J Transplant. 2021;22(1):71-84doi: 10.1111/ajt.16709.
Jouve, T., Laheurte, C., Noble, J., Weinhard, J., Daligault, M., Renaudin, A., Naciri Bennani, H., Masson, D., Gravelin, E., Bugnazet, M., Bardy, B., Malvezzi, P., Saas, P., & Rostaing, L. (2022). Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 22(1), 71-84. https://doi.org/10.1111/ajt.16709
Jouve, Thomas, et al. "Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates." American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 22,1 (2022): 71-84. doi: https://doi.org/10.1111/ajt.16709
Jouve T, Laheurte C, Noble J, Weinhard J, Daligault M, Renaudin A, Naciri Bennani H, Masson D, Gravelin E, Bugnazet M, Bardy B, Malvezzi P, Saas P, Rostaing L. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. Am J Transplant. 2022 Jan;22(1):71-84. doi: 10.1111/ajt.16709. Epub 2021 Jun 23. PMID: 34080291.
Copy Download .nbib Format: NLM
Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation.

The Journal of surgical research

Kosaka H, Kaibori M, Chu DI, Stucchi AF, Sekimoto M.
PMID: 34638093
J Surg Res. 2022 Feb;270:49-57. doi: 10.1016/j.jss.2021.08.038. Epub 2021 Oct 09.

BACKGROUND: Postoperative adhesions are a potentially life-threatening complication of abdominal surgery. We previously showed that substance P (SP), acting through the neurokinin-1 receptor (NK-1R), is an important early mediator of adhesiogenesis through its regulation of the tissue plasminogen activator/plasminogen...

Cite
Kosaka H, Kaibori M, Chu DI, et al. Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation. J Surg Res. 2021;270:49-57doi: 10.1016/j.jss.2021.08.038.
Kosaka, H., Kaibori, M., Chu, D. I., Stucchi, A. F., & Sekimoto, M. (2022). Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation. The Journal of surgical research, 27049-57. https://doi.org/10.1016/j.jss.2021.08.038
Kosaka, Hisashi, et al. "Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation." The Journal of surgical research vol. 270 (2022): 49-57. doi: https://doi.org/10.1016/j.jss.2021.08.038
Kosaka H, Kaibori M, Chu DI, Stucchi AF, Sekimoto M. Role of Substance P-Dependent Chemotactic Signaling in Postoperative Adhesion Formation. J Surg Res. 2022 Feb;270:49-57. doi: 10.1016/j.jss.2021.08.038. Epub 2021 Oct 09. PMID: 34638093.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 107 entries